Control of diabetes mellitus in the eastern province of Saudi Arabia: Results of screening campaign;Contrôle du diabète sucré dans la province orientale d'Arabie saoudite: Résultats de la campagne de dépistage

Eastern Mediterranean Health Journal

Volumn 16, Issue 6, 2010, Pages 621-629

  Al Baghli, N A ^a   Al Turki, K A ^a   Al Ghamdi, A J ^a   El Zubaier, A G ^b   Al Ameer, M M ^c   Al Baghli, F A ^c  

^a MINISTRY OF HEALTH   (Saudi Arabia)

^b IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY   (Saudi Arabia)

^c Al Amel Complex of Mental Health   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; GLUCOSE; GLUCOSE BLOOD LEVEL;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CAPILLARY BLOOD; DIABETES MELLITUS; DIABETIC DIET; DIASTOLIC BLOOD PRESSURE; EDUCATION; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPERTENSION; INCOME; MAJOR CLINICAL STUDY; MALE; MARRIAGE; OCCUPATION; PHYSICAL ACTIVITY; PREVALENCE; RISK FACTOR; SAUDI ARABIA; SMOKING; SYSTOLIC BLOOD PRESSURE; ANALYSIS OF VARIANCE; BLOOD; CHI SQUARE DISTRIBUTION; FOLLOW UP; HEALTH CARE QUALITY; MASS SCREENING; METABOLISM; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; SEDENTARY LIFESTYLE; SOCIOECONOMICS; STATISTICAL MODEL; TREATMENT OUTCOME;

ADULT; AGED; ANALYSIS OF VARIANCE; BLOOD GLUCOSE; CHI-SQUARE DISTRIBUTION; DIABETES MELLITUS; DIABETIC DIET; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPOGLYCEMIC AGENTS; LOGISTIC MODELS; MALE; MASS SCREENING; MIDDLE AGED; QUALITY OF HEALTH CARE; RISK FACTORS; SAUDI ARABIA; SEDENTARY LIFESTYLE; SMOKING; SOCIOECONOMIC FACTORS; TREATMENT OUTCOME;

EID: 77953771727     PISSN: 10203397     EISSN: None     Source Type: Journal    
DOI: 10.26719/2010.16.6.621     Document Type: Article

References (25)

1. Bloomgarden Z. The epidemiology of complications. Diabetes care, 2002, 25:924-32.
2. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet, 1998, 352:854-65.
3. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet, 1998, 352:837-53.
4. Ohkubo Y et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes research and clinical practice, 1995, 28:103-17.
5. Selvin E et al. Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Annals of internal medicine, 2004, 141:421-31.
6. Eastman RC et al. Model of complications of NIDDM. II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia. Diabetes care, 1997,20:735-44.
7. Eastman RC et al. Model of complications of NIDDM. I. Model construction and assumptions. Diabetes care, 1997, 20:725-34.
8. Stratton IM et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. British medical journal,2000, 321:405-12.
9. American Diabetes Association. Standards of medical care in diabetes-2008. Diabetes care, 2008, 31(Suppl. 1):S12-54.
10. Al-Ghamdi A et al. A community-based screening campaign for the detection of diabetes mellitus and hypertension in the eastern province, Saudi Arabia: methods and participation rate. Journal of family and community medicine, 2007, 14(3):91-7.
11. Chobanian AV et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension, 2003, 42:1206-52.
12. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New England journal of medicine, 1993, 329:977-986.
13. Brechner RJ et al. Ophthalmic examination among adults with diagnosed diabetes mellitus. Journal of the American Medical Association, 1993, 270:1714-8.
14. Beckles GL et al. Population-based assessment of the level of care among adults with diabetes in the US. Diabetes care, 1998, 21:1432-8.
15. Harris MI et al. Racial and ethnic differences in glycemic control of adults with type 2 diabetes. Diabetes care, 1999, 22:403-8.
16. Saydah SH, Fradkin J, Cowie CC. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. Journal of the American Medical Association, 2004, 291:335-42.
17. Peek ME, Cargill A, Huang ES. Diabetes health disparities: a systematic review of health care interventions. Medical care research and review, 2007, 64(5 Suppl.):101S-56S.
18. Pringle M et al. Influences on control in diabetes mellitus: patient, doctor, practice, or delivery of care? British medical journal, 1993, 306:630-4.
19. Bransome ED Jr. Financing the care of diabetes mellitus in the U.S. Background, problems, and challenges. Diabetes care, 1992, 15(Suppl. 1):1-5.
20. Norris SL, Engelgau MM, Narayan KM. Effectiveness of self-management training in type 2 diabetes: a systematic review of randomized controlled trials. Diabetes care, 2001, 24:561-87.
21. Padgett D et al. Meta-analysis of the effects of educational and psychosocial interventions on management of diabetes mel-litus. Journal of clinical epidemiology, 1988, 41:1007-30.
22. Norris SL et al. Self-management education for adults with type 2 diabetes: a meta-analysis of the effect on glycemic control. Diabetes care, 2002, 25:1159-71.
23. Naik AD et al. Improving hypertension control in diabetes mellitus: the effects of collaborative and proactive health communication. Circulation, 2008, 117:1361-8.
24. Cooper ME, Johnston CI. Optimizing treatment of hypertension in patients with diabetes. Journal of the American Medical Association, 2000, 283:3177-9.
25. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. British medical journal, 1998, 317:703-13.